Ming Xu
Shanxi Medical University(CN)First Hospital of Shanxi Medical University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Hepatitis C virus research, Epigenetics and DNA Methylation
Most-Cited Works
- → Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial(2018)120 cited
- → ELF3 promotes epithelial–mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma(2018)106 cited
- → Attenuation of Luteinizing Hormone Surges in Neuropeptide Y Knockout Mice(2000)76 cited
- → Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling(2013)60 cited
- → Ezrin promotes breast cancer progression by modulating AKT signals(2019)59 cited
- → Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway(2019)59 cited
- → β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers(2017)58 cited
- → The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast(2016)54 cited
- → Regulation of Hypothalamic Neuropeptide Y Y1 Receptor Gene Expression during the Estrous Cycle: Role of Progesterone Receptors*(2000)52 cited
- → Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production(2013)49 cited